April 27, 2019
Burlingame, California
Chinese American BioPharmaceutical Society (CABS)
Finnegan will co-host with the Chinese American Biopharmaceutical Society (CABS) an afternoon program discussing intellectual property strategies for biotech and pharmaceutical startup companies. Attorney Michael Liu Su will present "Recent Developments on Hot Technologies from an IP Perspective," and attorney Dr. Yieyie Yang will present "Due Diligence for Startups." Their sessions will be followed by a panel discussion on "Best Practices for Startups Needing to Develop Effective and Attractive IP Portfolios." The program will be held at Hanhai BioLabs in Burlingame, California. For more information and to register, visit the CABS website.
Webinar
Data and Market Exclusivity: An Update on China’s New Law and Comparisons to the US and Europe
November 19, 2026
Webinar
Seminar
The Augmented Practice 2026: Balancing AI Opportunity, Governance, and Risk
November 5, 2026
San Francisco
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.